| View |
|
DRP-7269-01
|
Levothyroxine (As Sodium)
|
Levothyrogen
|
25 mcg
|
Tablet
|
Thyroid Hormone Replacement
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
Automatic Renewal (E-AR)
|
06 March 2024
|
26 May 2029
|
| View |
|
DRP-15264 .
|
Clobetasol Propionate.
|
Clovate
|
0.5 mg/g (0.05% w/w)
|
Cream
|
Corticosteroid
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRHR-2318.
|
Isopropyl Alcohol
|
Land and Harper
|
70 mL/100 mL (70% v/v)
|
Solution
|
Antiseptic/Disinfectant
|
Jovash International, Inc.
|
Philippines
|
Initial
|
06 June 2024
|
06 June 2029
|
| View |
|
DRP-6317-07
|
Oxytocin
|
Ashxytin
|
10 IU/mL
|
Solution for Injection
|
Posterior Pituitary Lobe Hormone
|
Sanjivani Paranteral Ltd.
|
India
|
CLIDP Conversion
|
23 June 2023
|
12 January 2028
|
| View |
|
BRP-041-20
|
Enoxaparin sodium
|
Enoxar
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Anticoagulant
|
Brawn Laboratories Limited
|
India
|
CLIDP Conversion
|
08 July 2023
|
09 December 2025
|
| View |
|
BRP-041-21
|
Enoxaparin sodium
|
Bicanoxen 40
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Anticoagulant
|
Brawn Laboratories Ltd.
|
India
|
CLIDP Conversion
|
15 August 2023
|
09 December 2025
|
| View |
|
BRP-041-22
|
Enoxaparin sodium
|
None
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Antithrombotic agents
|
Brawn Laboratories Ltd.
|
India
|
CLIDP Conversion
|
12 November 2023
|
09 December 2025
|
| View |
|
BRP-041-23
|
Enoxaparin sodium
|
Noxever
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
Antithrombotic agents
|
Brawn Laboratories Ltd
|
India
|
CLIDP Conversion
|
13 December 2023
|
09 December 2025
|
| View |
|
DRP-12445
|
Apixaban
|
Embolis 5
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct Factor Xa Inhibitor)
|
|
|
Automatic Renewal (Variation)
|
04 November 2022
|
08 July 2027
|
| View |
|
DRP-13800-03
|
Co-Amoxiclav
|
Retavacyl 125
|
156.25 mg/5mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillin+Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
25 July 2024
|
22 November 2027
|
| View |
|
DRP-12921-05
|
Co-Amoxiclav
|
Retavacyl 250
|
312.5 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt. Ltd
|
India
|
CLIDP Conversion
|
25 July 2024
|
28 October 2027
|
| View |
|
DRP-11805-10
|
Co-Amoxiclav
|
Retavacyl 625
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-lactamase inhibitor)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 July 2024
|
05 May 2027
|
| View |
|
DRP-14595-06
|
Acetylcysteine
|
Goflem 600
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
25 July 2024
|
20 October 2028
|
| View |
|
DRP-11087-05
|
Co-Amoxiclav
|
Healclav
|
457 mg/ 5 mL
|
Powder for Oral Suspension (Raspberry Flavor)
|
Antibacterial (Penicillin/Beta Lactamase Inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
26 April 2023
|
03 February 2027
|
| View |
|
DRP-11087-04
|
Co-Amoxiclav
|
Voxiclav
|
457 mg/ 5 mL
|
Powder for Oral Suspension (Raspberry Flavor)
|
Antibacterial (Penicillin/Beta Lactamase Inhibitor
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
26 April 2023
|
03 February 2027
|
| View |
|
DRP-11087-6
|
Co-Amoxiclav
|
Medavox 457
|
457 mg/ 5 mL
|
Powder for Oral Suspension (Raspberry Flavor)
|
Antibacterial (Penicillin/Beta Lactamase Inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
19 May 2023
|
03 February 2027
|
| View |
|
DRP-11087-03
|
Co-Amoxiclav
|
Clavxicure
|
457 mg/ 5 mL
|
Powder for Oral Suspension (Raspberry Flavor)
|
Antibacterial (Penicillin/Beta Lactamase Inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
07 March 2023
|
03 February 2027
|
| View |
|
DRP-7563-06
|
Amlodipine (as besilate)
|
Aml-5
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
28 February 2023
|
17 December 2025
|
| View |
|
DRP-7376-06
|
Amlodipine (as besilate)
|
Retavasc-10
|
10 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
07 December 2022
|
26 February 2026
|
| View |
|
DRP-7376-07
|
Amlodipine (as besilate)
|
Aml-10
|
10 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
28 February 2023
|
26 February 2026
|